According to a survey conducted among U.S. and Canadian pharmaceutical executives the major challenge for companies during the coronavirus pandemic is engaging and retaining patients for clinical trials. Another big challenge is the lack of time for patient education about studies.
Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020
Characteristic
Percentage of respondents
Engaging and retaining patients
38
Monitoring visit prep
36
Follow-up with current study subjects to resume their study visits
29
Pre-screening patients/referrals from outside sources
26
Time for patient education about studies
22
Investigator site file upkeep
22
Patient phone screening and scheduling
22
EDC query resolution
19
Reviewing my site database/chart review to find potential subjects
17
EDC data entry
17
Not enough staff and/or time to devote to devote to study
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IQVIA. (June 23, 2020). Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020 [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA. "Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020." Chart. June 23, 2020. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA. (2020). Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA. "Key Challenges for Pharmaceutical Companies during The Covid-19 Pandemic as of 2020." Statista, Statista Inc., 23 Jun 2020, https://www.statista.com/statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA, Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020 Statista, https://www.statista.com/statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/ (last visited December 21, 2024)
Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020 [Graph], IQVIA, June 23, 2020. [Online]. Available: https://www.statista.com/statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
